Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient

Sarr MG Kendrick ML Nagorney DM Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms Surg Clin North Am 200181 3 497–50910.1016/S0039-6109(05)70139-0

Luce JA Murray J Nadel J Lymphoma, lymphoproliferative diseases and other primary malignant tumors Textbook of respiratory medicine 20003 Philadelphia, PA Saunders 1453–1468

Bullock WE Goldman L Bennett JC Nocardiosis Cecil textbook of medicine 200021 Philadelphia, PA Saunders 1715–1717

Dismukes WE Goldman L Bennett JC Histoplasmosis, coccidiomycosis, blastomycosis Cecil textbook of medicine 200021 Philadelphia, PA Saunders 1860–1866

Keane J Gershon S Wise RP Mirabile-Levens E Kasznica J Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 2001345 15 1098–110410.1056/NEJMoa011110

Carswell EA Old LJ Kassel RL Green S Fiore N Williamson B An endotoxin-induced serum factor that causes necrosis of tumors Proc Natl Acad Sci U S A 197572 9 3666–367010.1073/pnas.72.9.3666

Beutler B Mahoney J Le Trang N Pekala P Cerami A Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells J Exp Med 1985161 5 984–99510.1084/jem.161.5.984

Tracey KJ Fong Y Hesse DG Manogue KR Lee AT Kuo GC Lowry SF Cerami A Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 1987330 6149 662–66410.1038/330662a0

Feldmann M Development of anti-TNF therapy for rheumatoid arthritis Nat Rev Immunol 20022 5 364–37110.1038/nri802

Nathan CF Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes Clin Invest 198780 6 1550–156010.1172/JCI113241

Criscione LG St Clair EW Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases Curr Opin Rheumatol 200214 3 204–21110.1097/00002281-200205000-00002

Nathan CF Ehrt S Rom W Garay S Nitric oxide and tuberculosis Tuberculosis 2003 1 Sage CA: Los Angeles, CA Lippincott

Kindler V Sappino AP Grau GE Piguet PF Vassalli P The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection Cell 198956 5 731–74010.1016/0092-8674(89)90676-4

Bean AG Roach DR Briscoe H France MP Korner H Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin J Immunol 1999162 6 3504–3511

Roach DR Bean AG Demangel C France MP Briscoe H Britton WJ TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection J Immunol 2002168 9 4620–4627

Trevejo JM Marino MW Philpott N Josien R Richards EC Elkon KB Falck-Pedersen E TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection Proc Natl Acad Sci U S A 200198 21 12162–1216710.1073/pnas.211423598

Shiloh MU MacMicking JD Nicholson S Brause JE Potter S Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase Immunity 199910 1 29–3810.1016/S1074-7613(00)80004-7

Maianski NA Roos D Kuijpers TW Tumor necrosis factor {alpha} induces a caspase-independent death pathway in human neutrophils Blood 2002101 5 1987–199510.1182/blood-2002-02-0522

Hodge-Dufour J Marino MW Horton MR Jungbluth A Burdick MD Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor Proc Natl Acad Sci U S A 199895 23 13806–1381110.1073/pnas.95.23.13806

Flynn JL Goldstein MM Chan J Triebold KJ Pfeffer K Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 19952 6 561–57210.1016/1074-7613(95)90001-2

Paget SA (2001) Postmarketing adverse event data for TNF-alpha antagonists. <http://www.hss.edu/Professionals/Conditions/Rheumatoid-Arthritis/Postmarketing-Adverse-Event-TNF-Alpha> (Accessed on December 7, 2006)